Teladoc Health, Inc.
Company Stats
- Market Cap
- $1.1B
- as of Sep 30, 2026
- Shares Outstanding
- 181.7M
- Free Float
- 88.2%
Income Statement
- Revenue
- $2.5B
- Operating Income
- -$263.0M
- Net Income
- -$200.3M
- Non-cash Impairment
- $71.8M
- Revenue Growth, 3Y
- 1.7%
- FCF Margin, 3Y Avg
- 11.8%
- FCF Margin, Worst Year
- 11.0%
Cash Flow
- Free Cash Flow
- $285.5M
- FCF Yield
- 27.1%
- Owner FCF Yield
- 19.5%
Balance Sheet
- Cash & Equivalents
- $781.1M
Returns & Capital
- SBC, 3Y Avg
- $142.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $2.5B | $285.5M | 11.3% |
| FY2024 | $2.6B | $282.9M | 11.0% |
| FY2023 | $2.6B | $338.6M | 13.0% |
| FY2022 | $2.4B | $172.8M | 7.2% |
| FY2021 | $2.0B | $185.5M | 9.1% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 12, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges